Format

Send to

Choose Destination
Haematologica. 2018 Mar;103(3):e106-e109. doi: 10.3324/haematol.2017.182642. Epub 2017 Dec 14.

Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm.

Author information

1
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA rwalter@fredhutch.org.
2
Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
3
Department of Epidemiology, University of Washington, Seattle, WA, USA.
4
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
5
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
6
Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
7
Stanford University, CA, USA.
8
Jazz Pharmaceuticals, Ewing, NJ, USA.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center